U.S. Stocks Regaining Ground Following Two-Day Pullback

U.S. equities rallied Thursday with the Dow up 296.96 points (0.6%) to 49,446.59, the S&P 500 up 39.70 points (0.6%) to 6,966.30 and the Nasdaq up 177.33 points (0.8%) to 23,649.08, led by a 6.5% surge in Taiwan Semiconductor after it reported a sharp rise in Q4 profits and announced larger-than-expected capital spending and guidance implying 30% growth in 2026. Semiconductor and computer hardware indices outperformed (Philadelphia Semiconductor Index +3.0% to an intraday record; NYSE Arca Computer Hardware Index +2.5%), supporting renewed confidence in the AI investment theme. Economic data were also supportive as weekly initial jobless claims unexpectedly dropped to 198,000 (versus 215,000 expected), while the 10-year Treasury yield ticked up 1.8 bps to 4.158%.

Analysis

Market structure: TSMC's blowout quarter and raised capex (guiding ~30% revenue growth for 2026) re-rates semiconductor equipment, foundry suppliers and AI compute beneficiaries (SMH, NVDA-adjacent suppliers) while pressuring defensive pharma (XLV) and long-duration software. The near-term demand signal is concrete — Philly Semiconductor +3% and TSM +6.5% — implying OEMs will accelerate orders for leading nodes over the next 6–18 months, supporting pricing power for advanced nodes but raising risk of cyclical inventory if capex overshoots execution.

Risk assessment: Key tails are geopolitics/export controls (new US/Taiwan/China restrictions) and capex overbuild leading to 2027–2028 ASP erosion; both are low-probability but high-impact. Immediate effects (days) are momentum-driven; short-term (weeks–months) hinge on order flow and supplier book-to-bill; long-term (quarters–years) depends on realized AI demand vs. incremental capacity — set unwind triggers (10-yr yield >4.5% or TSM 2026 guidance <15% growth).

Trade implications: Favor long, selective semiconductor exposure via SMH or TSM, size 1–3% per trade, using capped-risk options (6–9 month call spreads 30–50% OTM) to limit downside; rotate 2–4% from defensive healthcare (XLV) into semis over 4–12 weeks. Hedge macro with shorter-duration fixed-income or buy 3–6 month protection (puts on QQQ) if yields breach 4.25% rapidly.

Contrarian angles: Consensus assumes persistent AI demand; missing is timing — elevated capex can create oversupply by 2027 similar to 2018–2019 cycles, compressing foundry margins. Reaction may be partially overdone near-term; use sub-12% pullbacks in TSM or 8–10% weakness in SMH as tactical accumulation spots, and beware margin squeeze if wafer starts outpace AI server deployments.

Key Decisions for Investors

• Establish a 2% position in TSM (ticker: TSM) via a 6–9 month call spread ~30–50% OTM to target 30–60% upside while capping premium loss; trim/stop if TSM falls >12% from entry or if company guidance for 2026 drops below 15% growth.
• Rotate 3% of portfolio from XLV (healthcare ETF) into SMH (VanEck Semiconductor ETF) over 4 weeks — implement as 1.5% long SMH and 1.5% short XLV pair trade to capture relative re-rating; close or reassess after 3 months or if SMH outperforms XLV by >15%.
• Buy 3–6 month protective puts on QQQ (e.g., 5–7% OTM) sized to cover 1–2% of portfolio if 10-year yield breaches 4.25% intraday; this hedge addresses a rapid risk-off that would hurt high-multiple tech beyond semiconductors.
• Monitor three catalysts rigorously: TSM quarterly conference call and 2026 guidance (within 30 days), US-Taiwan/China export policy developments (next 90 days), and US monthly payrolls/jobless claims (monthly); reduce semiconductor exposure by 50% if jobless claims rise >40k to >240k or 10-yr yield surpasses 4.5% persistent for 5 trading days.